Duke-NUS in Singapore partners with Swedish biotech startup Alder Therapeutics
Therapeutics | News | 0 Comment | 24 Mar, 2023
In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related...Read more
Australia injects $3M funding for world-first drug trial for poorly controlled epilepsy
Therapeutics | News | 0 Comment | 22 Mar, 2023
Epilepsy affects over 150,000 Australians, and 50 million globally, with one-third struggling to control their condition...Read more
Singapore finds new way to clear brain waste linked to Alzheimer's disease
Therapeutics | News | 0 Comment | 17 Mar, 2023
A newly discovered “energy switch” in the immune cells of the brain may lead to the development of drugs for...Read more
Australia uses smart nanotechnology for more accurate delivery of insulin
Therapeutics | News | 0 Comment | 14 Mar, 2023
More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to...Read more
World’s first study to prove myopia prevention in children by low-concentration atropine drops
Therapeutics | News | 0 Comment | 14 Mar, 2023
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...Read more
Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome
Therapeutics | News | 0 Comment | 13 Mar, 2023
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...Read more
Monash University in Australia leads $15M mitochondrial donation clinical trial
Therapeutics | News | 0 Comment | 13 Mar, 2023
Around 50 Australian children are born every year with devastating mitochondrial disease, with an expected lifespan of o...Read more
Singapore develops novel therapy for treating vancomycin-resistant bacterial infections
Therapeutics | News | 0 Comment | 08 Mar, 2023
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for...Read more
"We will enable researchers in Singapore to conduct homegrown large-scale population health studies"
Therapeutics | Opinion | 0 Comment | 07 Mar, 2023
Please share more details about the technology that has been transferred by Olink to NUS? What is so unique...Read more
Singapore accelerates precision medicine through next-generation proteomics
Therapeutics | News | 0 Comment | 07 Mar, 2023
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medi...Read more
Japan discovers potential treatment of autoimmune diseases
Therapeutics | News | 0 Comment | 07 Mar, 2023
Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune disease...Read more
European Union approves first gene therapy for hemophilia B
Therapeutics | News | 0 Comment | 23 Feb, 2023
Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...Read more
Korean firms to develop novel microbiome treatment for Parkinson's disease
Therapeutics | News | 1 Comment | 21 Feb, 2023
South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...Read more
New Zealand approves globally regarded soft-tissue sarcoma therapy
Therapeutics | News | 0 Comment | 17 Feb, 2023
Singapore-headquartered biopharmaceutical company Specialised Therapeutics (ST) has announced that its portfolio therapy...Read more
Australia discovers receptor that blocks COVID-19 infection
Therapeutics | News | 0 Comment | 14 Feb, 2023
Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...Read more
Japan develops method to design new peptide therapeutics for combating antibiotic resistance
Therapeutics | News | 0 Comment | 13 Feb, 2023
Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...Read more
“We need to foster risky projects that can have large rewards”
Therapeutics | Opinion | By Ayesha Siddiqui | 4 Comment | 07 Feb, 2023
What is Anticancer Bioscience’s competitive edge and what is unique about the pipeline you are developing?&n...Read more
Singapore is beginning to see benefits of investing in technological aspect of cancer treatment
Therapeutics | Opinion | By Chew Huat Seng, Managing Director, Hitachi Asia, Malaysia | 4 Comment | 06 Feb, 2023
Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...Read more